Breaking News Instant updates and real-time market news.

KEYS

Keysight Technologies

$105.80

-0.5 (-0.47%)

16:07
11/26/19
11/26
16:07
11/26/19
16:07

Keysight Technologies sees Q1 EPS $1.04-$1.10, consensus $1.05

Sees Q1 revenue $1.045B-$1.065B, consensus $1.05B.

  • 26

    Nov

  • 02

    Dec

KEYS Keysight Technologies
$105.80

-0.5 (-0.47%)

09/09/19
DBAB
09/09/19
NO CHANGE
DBAB
Buy
Deutsche analysis suggests 40% upside potential in Keysight Technologies
Deutsche Bank analyst Brian Yun says his sum-of-the-parts analysis suggests 40%-plus upside potential in shares of Keysight Technologies. The analyst sees a pathway to $140 levels for the stock via a sum-of-the-parts valuation. Software is a "meaningful differentiator" for the company versus other test and measurement peers, Yun tells investors in a research note. He highlights the "depth" of Keysight's software portfolio, design wins, and industry partnerships. Further, software should accelerate the company's sales growth and margin expansion ahead of consensus and buy-side expectations, warranting a higher multiple for the stock, says Yun.
10/17/19
SUSQ
10/17/19
INITIATION
Target $115
SUSQ
Positive
Keysight Technologies initiated with a Positive at Susquehanna
Susquehanna analyst Mehdi Hosseini initiated coverage of Keysight Technologies with a Positive rating and $115 price target.
10/17/19
SUSQ
10/17/19
INITIATION
Target $115
SUSQ
Positive
Susquehanna starts Keysight Technologies with Positive, $115 price target
Susquehanna analyst Mehdi Hosseini initiated coverage of Keysight Technologies with a Positive rating and $115 price target. 5G is the key multi-year secular growth driver, and Keysight offers a broad range of equipment to materialize growth from the different stages of 5G, Hosseini tells investors in a research note. The analyst believes the rollout of 5G worldwide comes with "significant opportunity for the company."
11/18/19
BOFA
11/18/19
INITIATION
Target $115
BOFA
Keysight Technologies resumed with Neutral at BofA/Merrill
BofA/Merrill analyst David Ridley-Lane resumed coverage of Keysight Technologies with a Neutral rating and $115 price target. The analyst says the stock gives investors exposure to the "increasing power of mobile networks and the new opportunities they enable," while its $650M R&D budget gives the company product differentiation and generates margin expansion. Ridley-Lane adds that his price target models a 23-times forward earnings multiple, which is in line with Keysight's peers.

TODAY'S FREE FLY STORIES

TSLA

Tesla

$357.90

-1.8 (-0.50%)

15:56
12/13/19
12/13
15:56
12/13/19
15:56
Periodicals
NHTSA to probe December 7 crash of Tesla Model 3, Reuters reports »

The U.S. National Highway…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

  • 23

    Mar

TME

Tencent Music

$11.46

-0.54 (-4.50%)

15:55
12/13/19
12/13
15:55
12/13/19
15:55
Options
Tencent put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HBAYF

Hudson's Bay

$0.00

(0.00%)

15:46
12/13/19
12/13
15:46
12/13/19
15:46
Periodicals
Hudson's Bay take-private deal fails to secure investor support, Reuters says »

Hudson's Bay has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HBAYF

Hudson's Bay

$0.00

(0.00%)

15:43
12/13/19
12/13
15:43
12/13/19
15:43
Periodicals
Breaking Periodicals news story on Hudson's Bay »

Hudson's Bay group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DB

Deutsche Bank

$7.48

-0.095 (-1.26%)

15:40
12/13/19
12/13
15:40
12/13/19
15:40
Periodicals
Deutsche Bank mulls deep cuts to bonuses this year, Bloomberg says »

Deutsche Bank is weighing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IWM

iShares Trust Russell 2000 Index Fund

$163.03

-0.92 (-0.56%)

, RUT

Russell 2000 Index

$0.00

(0.00%)

15:19
12/13/19
12/13
15:19
12/13/19
15:19
Technical Analysis
On The Fly: Weekly technical notes for Russell 2000 »

For the week, the Russell…

IWM

iShares Trust Russell 2000 Index Fund

$163.03

-0.92 (-0.56%)

RUT

Russell 2000 Index

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$60.31

-0.55 (-0.90%)

, XLB

S&P Select Materials SPDR

$60.50

-0.42 (-0.69%)

15:18
12/13/19
12/13
15:18
12/13/19
15:18
Technical Analysis
On The Fly: Weekly technical notes for S&P 500 »

The S&P 500 (SPX)…

XLE

Energy Select Sector SPDR

$60.31

-0.55 (-0.90%)

XLB

S&P Select Materials SPDR

$60.50

-0.42 (-0.69%)

XLK

Technology Select Sector SPDR

$89.50

0.61 (0.69%)

XLI

Industrial Select Sector SPDR

$81.67

-0.25 (-0.31%)

XLF

Financial Select Sector

$30.71

-0.11 (-0.36%)

XLU

Utilities SPDR

$63.39

0.53 (0.84%)

SPY

SPDR S&P 500 ETF Trust

$317.32

0.18 (0.06%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
12/13/19
12/13
15:17
12/13/19
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
12/13/19
12/13
15:16
12/13/19
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DELL

Dell Technologies

$49.35

-0.15 (-0.30%)

, NTNX

Nutanix

$32.95

0.34 (1.04%)

15:15
12/13/19
12/13
15:15
12/13/19
15:15
Periodicals
Dell looking to broaden infrastructure lead on Nutanix, CRN says »

Dell Technologies (DELL)…

DELL

Dell Technologies

$49.35

-0.15 (-0.30%)

NTNX

Nutanix

$32.95

0.34 (1.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 16

    Dec

  • 09

    Jan

  • 27

    Feb

GOOS

Canada Goose

$40.14

-0.005 (-0.01%)

15:14
12/13/19
12/13
15:14
12/13/19
15:14
Periodicals
DA Davidson analyst sees Canada Goose prices falling, NY Post says »

DA Davidson analyst John…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$357.87

-1.83 (-0.51%)

15:04
12/13/19
12/13
15:04
12/13/19
15:04
Periodicals
NHTSA to probe December 7 crash of Tesla Model 3, Reuters reports »

The agency will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

  • 23

    Mar

LYV

Live Nation

$70.64

1.2 (1.73%)

15:02
12/13/19
12/13
15:02
12/13/19
15:02
Periodicals
DoJ preparing to take legal action against Live Nation over ticketing, WSJ says »

The Department of Justice…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:00
12/13/19
12/13
15:00
12/13/19
15:00
General news
Treasury Market Summary »

Treasury Market Summary:…

LYV

Live Nation

$70.63

1.19 (1.71%)

14:57
12/13/19
12/13
14:57
12/13/19
14:57
Periodicals
DOJ preparing to take legal action against Live Nation over ticketing, WSJ says »

The Department of Justice…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EGRX

Eagle Pharmaceuticals

$59.90

0.73 (1.23%)

, LLY

Eli Lilly

$121.30

-0.39 (-0.32%)

14:55
12/13/19
12/13
14:55
12/13/19
14:55
Hot Stocks
Eagle Pharmaceuticals reports settlement agreement with Eli Lilly on Pemfexy »

Eagle Pharmaceuticals…

EGRX

Eagle Pharmaceuticals

$59.90

0.73 (1.23%)

LLY

Eli Lilly

$121.30

-0.39 (-0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

  • 17

    Dec

  • 30

    Jan

BMY

Bristol-Myers

$64.01

0.05 (0.08%)

, GILD

Gilead

$65.67

-1.97 (-2.91%)

14:52
12/13/19
12/13
14:52
12/13/19
14:52
Periodicals
Bristol-Myers awarded $585M in damages in patent win over Gilead, Bloomberg says »

Bristol-Myers Squibb…

BMY

Bristol-Myers

$64.01

0.05 (0.08%)

GILD

Gilead

$65.67

-1.97 (-2.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

BRFRF

Burford Capital

$0.00

(0.00%)

14:46
12/13/19
12/13
14:46
12/13/19
14:46
Hot Stocks
Muddy Waters' Block says still short Burford Capital »

Muddy Waters' Carson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANDE

Andersons

$24.03

-0.35 (-1.44%)

14:37
12/13/19
12/13
14:37
12/13/19
14:37
Hot Stocks
Andersons raises dividend to 17.5c from 17c per share »

The Andersons announces a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNDM

TNDM

, MDT

Medtronic

$113.56

1.17 (1.04%)

14:36
12/13/19
12/13
14:36
12/13/19
14:36
Recommendations
TNDM, Medtronic analyst commentary  »

Craig-Hallum reiterates…

TNDM

TNDM

MDT

Medtronic

$113.56

1.17 (1.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

BMY

Bristol-Myers

$64.19

0.23 (0.36%)

, GILD

Gilead

$65.76

-1.88 (-2.78%)

14:30
12/13/19
12/13
14:30
12/13/19
14:30
Periodicals
Bristol-Myers awarded $585M in damages in patent win over Gilead, Bloomberg says »

Bristol-Myers (BMY) was…

BMY

Bristol-Myers

$64.19

0.23 (0.36%)

GILD

Gilead

$65.76

-1.88 (-2.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
12/13/19
12/13
14:17
12/13/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
12/13/19
12/13
14:16
12/13/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VOO

Vanguard S&P 500 ETF

$291.59

0.33 (0.11%)

, IVV

iShares Core S&P 500

$319.25

0.36 (0.11%)

14:08
12/13/19
12/13
14:08
12/13/19
14:08
Technical Analysis
On The Fly: ETF fund flow highlights »

For the second week,…

VOO

Vanguard S&P 500 ETF

$291.59

0.33 (0.11%)

IVV

iShares Core S&P 500

$319.25

0.36 (0.11%)

XLE

Energy Select Sector SPDR

$60.65

-0.21 (-0.35%)

XLF

Financial Select Sector

$30.74

-0.08 (-0.26%)

QQQ

Invesco QQQ Trust

$207.32

0.76 (0.37%)

SPY

SPDR S&P 500 ETF Trust

$317.43

0.29 (0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNDM

TNDM

14:01
12/13/19
12/13
14:01
12/13/19
14:01
Hot Stocks
Tandem Diabetes up 5% upon resumption following FDA approval news »

After resuming trading,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.